STATE FATALITY SURVEILLANCE AND FIELD INVESTIGATIONS OF OCCUPATIONAL INJURIES:
FATALITY ASSESSMENT AND CONTROL EVALUATION (FACE)
Release Date: December 14, 2000
RFA: OH-01-003
National Institute for Occupational Safety and Health
Letter of Intent Receipt Date: January 12, 2001
Application Receipt Date: February 22, 2001
NOTE: Current FACE awardees should follow the instructions in the
application kit for competing renewal applications (PHS 398, page 16, item C.
Preliminary Studies/Progress Report).
PURPOSE
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2001 funds for cooperative agreements to
build State capacity for conducting traumatic occupational fatality
surveillance, investigation and intervention activities using a fatality
assessment and control evaluation (FACE) model. The objectives of this
State- based program are to identify work environments that place workers at
a high risk for fatal injury, identify the risk factors for these fatal
injuries, and develop, disseminate and evaluate prevention strategies. The
ultimate goal of this FACE program is to reduce the national burden for
traumatic occupational fatalities through the development of effective
prevention measures at the State and national level. Applications are sought
that demonstrate a high potential for achieving these objectives.
HEALTHY PEOPLE 2010
CDC is committed to achieving the health promotion and disease prevention
objectives of Healthy People 2010, a national activity to reduce morbidity
and mortality and improve the quality of life. This announcement is related
to the focus area of Occupational Safety and Health. For information on the
conference copy of Healthy People 2010, visit the internet site:
http://www.health.gov/healthypeople.
ELIGIBILITY REQUIREMENTS
Applications may be submitted by State health and labor departments or by
other State or territorial health agencies that have occupational safety and
health responsibilities. This eligibility includes health departments or
other official organizational authority (agency or instrumentality) of the
District of Columbia, the Commonwealth of Puerto Rico, any territory or
possession of the United States, and federally recognized Indian tribal
governments, Indian tribes, or Indian tribal organizations. Applicants other
than health or labor departments must apply in collaboration with and through
their State and territorial health department. Awards will be limited to
those organizations that can exercise public health authority for
intervention into occupational safety and health problems. Program
activities, however, may not be carried out by departmental divisions that
are responsible for enforcement of occupational and health standards. Only
one application per State will be accepted under this announcement.
MECHANISM OF SUPPORT
The administrative and funding instrument to be used for this program will be
a cooperative agreement (U01), an assistance mechanism, in which substantial
NIOSH scientific and/or programmatic involvement with the awardee is
anticipated during performance of the activity. Under the cooperative
agreement, the NIOSH purpose is to support and/or stimulate the recipient"s
activity by involvement in and otherwise working jointly with the award
recipient in a partner role. Details of the responsibilities, relationships
and governance of the study to be funded under cooperative agreement(s) are
discussed later in this document under the section Terms and Conditions of
Award.
The total project period for an application submitted in response to this
present RFA may not exceed five (5) years. The anticipated award date is
September 1, 2001. The award and level of support depends on receipt of
applications of high scientific merit. Although this program is provided for
in the financial plans of NIOSH, the award pursuant to this RFA is contingent
upon the availability of funds for this purpose.
AVAILABILITY OF FUNDS
Approximately $600,000 is available in FY 2001 to make 4 - 6 awards under
this RFA. For each award, the range of total costs (direct plus facilities
and administration) per year is anticipated to be between $75,000 and
$150,000 (maximum).
Awards will be made for a 12-month budget period within a project period up
to 5 years. Continuation awards within the project period will be made on
the basis of satisfactory progress and availability of funds in future years.
Use of Funds
Applicants should allocate funds for travel to attend meetings as indicated
in the section FACE Consortium and Coordination Committee (CC) Meetings.
PREAPPLICATION CONFERENCE CALL
Applicants are invited by NIOSH to participate in a preapplication technical
assistance telephone conference call on January 22, 2001 at 1:00 PM (Eastern
time) to discuss: programmatic issues regarding this program, how to apply,
and questions regarding the content of the RFA. The conference name is
Fatality Assessment and Control Evaluation (FACE) program. The telephone
bridge number is 404-639-3277. Interested parties will need the conference
code (679146) to participate.
RESEARCH OBJECTIVES
Background
Traumatic occupational fatalities represent a public health problem of
significant proportion. Based on data from the National Traumatic
Occupational Fatalities (NTOF) surveillance system, there were over 94,000
occupational injury deaths in the United States for the period 1980-1995
[CDC, 1999]. Recent data from the Bureau of Labor Statistics documented
6,023 work- related injury deaths in 1999 [BLS, 2000]. Surveillance data
such as NTOF and those from the Bureau of Labor Statistics are useful for
setting research and prevention priorities as they identify common causes of
death and worker groups experiencing large numbers and/or rates of
occupational injury death. However, more in-depth information is frequently
required to understand the circumstances and contributors to fatal injuries
in order to develop effective preventive measures.
The state-based FACE program began in 1983 within NIOSH to provide in-depth
causal information on targeted types of work injury deaths. FACE was
expanded in 1989 to multiple States to provide more timely and in-depth
information than was available from existing surveillance systems with the
goal of taking advantage of the individual State data to make national
recommendations. State-based FACE programs permit the States to develop a
network of organizations which voluntarily report occupational fatalities and
link these surveillance activities to appropriate field investigations and to
the development and dissemination of prevention strategies to those who could
intervene in the workplaces within the State. In-depth, on-site
investigations have been conducted on fatalities resulting from targeted
causes of death that have included confined spaces, electrocutions, machine-
related falls from elevation and logging. Numerous articles, monographs,
hazard identifications and alerts have been written that detail findings on
these targeted causes of death. In 1999, the in-depth on-site investigation
targets were reassessed and revised to include deaths associated with
machinery, deaths of youths under 18 years of age, and street/highway
construction work zone fatalities.
Purpose
NIOSH seeks to build upon the past experience in state-based fatality
surveillance to increase the base of knowledge to prevent work-related injury
deaths nationwide in the currently identified priority areas as well as other
occupations that may be identified as a result of data analysis or new
prevention opportunities. Through an in depth analysis of data on
interactions of the worker, the work environment, and work processes,
prevention/intervention strategies aimed at reducing fatal injuries in the
workplace can be developed.
An integral part of this initiative is the establishment of a Fatality
Assessment and Control Evaluation (FACE) Consortium. For this program, it is
important that data elements which will be shared between awardees are
managed in a uniform and compatible format. Because much of the shared data
elements are centered on job tasks and workers, a critical role of the FACE
Consortium will be to assure that the fatality data are uniform and
comprehensive in order to achieve across state assessments. In addition, for
the detailed investigations, the methods and data should have sufficient
commonality to allow for analyses across the States as well as development of
prevention recommendations. The FACE Consortium will establish a
Coordination Committee (CC), comprised of one voting representative from each
member of the consortium, to serve as the main governing board for the
conduct of this research program. The CC will serve as an advisory body for
the common or shared protocols to be used in the studies. NIOSH staff will
serve as non- voting members of the CC.
A Data Center may be established for this program through a competitive,
peer- reviewed process. If established, each recipient will be responsible
for providing data to the Data Center in a uniform fashion that is determined
by the CC. This center will serve as the data resource for the analysis by
the consortium investigators of the pooled data from all work sites in
collaboration with the FACE Consortium. This Data Center will serve as a
common repository for data, and these combined data will be available for all
members of the FACE Consortium.
Through the FACE Consortium, it is anticipated that critical risk factors for
fatal traumatic occupational injuries will be better defined at both the
State and national level, so that prevention and intervention strategies can
be developed. It is anticipated that practitioners in occupational safety
and health will be able to use the results from this project to more quickly
and reliably discriminate job tasks that elevate risks for fatal traumatic
injuries. With such knowledge, effective job design changes or interventions
can be developed that reduce occupational traumatic fatalities. The FACE
Consortium will combine the expertise and resources of NIOSH research staff
with those of external collaborators. Individual investigators are
encouraged to analyze and publish data on their respective work sites as soon
as feasible.
Objectives
The ultimate goal of the FACE project is to reduce traumatic occupational
fatalities within the States and throughout the nation. NIOSH seeks project
applications that assist in building State capacity for conducting
occupational fatality surveillance, on-site investigations, and for
developing and disseminating hazard prevention strategies. The objectives of
the State- based FACE project are to (1) identify work environments that
place workers at high risk for fatal injury, (2) identify potential risk
factors, and (3) formulate and disseminate prevention strategies to those who
can intervene in the workplace. Applications are sought that demonstrate a
high potential for implementing a balanced program that includes occupational
fatality surveillance, field investigation of priority category fatalities,
and development and dissemination of preventive strategies.
Thus, applications which are responsive to the goals of this RFA should
include detailed study plans for the following three areas.
o A surveillance system to be used at the State level. This surveillance
system should enable the State to identify all traumatic occupational
fatalities occurring within the State in a timely fashion to allow
investigation of targeted fatalities. The investigator should include plans
for data management and quality control.
o A plan for the conduct of on-site investigations on specific traumatic
occupational fatalities. Investigators should include the rationale and
criteria to be used for the selection of on-site investigations.
Investigators are encouraged to consider the NIOSH FACE investigative model
cited in the useful references section for guidance on the development of a
traumatic occupational fatality protocol.
o Development and evaluation of prevention strategies for reducing the
incidence of traumatic occupational injuries and fatalities at the State
level.
USEFUL REFERENCES
National Institute for Occupational Safety and Health. National Occupational
Research Agenda. Cincinnati, OH: U.S. Department of Health and Human
Services, Public Health Service, Centers for Disease Control and Prevention,
National Institute for Occupational Safety and Health, DHHS (NIOSH)
Publication No.96-115 (http://www.cdc.gov/niosh/nora.html).
Morbidity and Mortality Weekly Report (MMWR). A Framework for Assessing the
Effectiveness of Disease and Injury prevention. March 27, 1992/Vol.41/Jn.
The MMWR can be accessed through the world-wide Web at:
http://www.cdc.gov/mmwr/preview/mmwrhtml/00016403.htm
NIOSH FACE Program: National Institute for Occupational Safety and Health
website at: http://www.cdc.gov/niosh/face/faceweb.html
FACE CONSORTIUM AND COORDINATION COMMITTEE (CC) MEETINGS
Applicants should include in their budget support for the PI and one other
person from their institution integrally involved in the project to attend an
annual program meeting of the FACE Consortium. The meeting will be of two or
three days duration and will be held at a site mutually acceptable to study
collaborators. The initial meeting will be in Morgantown, WV.
The applicant should also budget for attendance by the PI at two CC meetings
during the first year and two in each subsequent year. For budget
preparation and project planning purposes, it should be assumed that these
meetings will be held in Morgantown, WV. However, the CC will determine
later where and when recurring CC meetings will be held. The CC chair will
coordinate the meetings to review and assess overall progress and provide the
opportunity for investigators to exchange information and discuss research
issues.
TERMS AND CONDITIONS OF AWARD
The Terms and Conditions of Award, below, will be incorporated in all awards
issued as a result of this RFA. It is critical that each applicant include
specific plans for responding to these terms. These special Terms of Award
are in addition to and not in lieu of otherwise applicable OMB administrative
guidelines, HHS Grant Administration Regulations at 45 CFR Parts 74 and 92,
and PHS Grants Policy Statement.
Under the cooperative agreement, the NIOSH purpose is to support and/or
stimulate the recipient"s activity by involvement in, and otherwise working
jointly with, the award recipient in a partner role, but it is not to assume
direction, prime responsibility, or a dominant role in the activity.
Consistent with this concept, the dominant role and prime responsibility for
the activity resides with the awardee(s) for the project as a whole, although
specific tasks and activities in carrying out the studies will be shared
among the awardees and the NIOSH collaborators where appropriate, including
the following.
1. Recipient Responsibilities
The recipient will coordinate project activities, scientifically and
administratively, at the awardee institution and at the other sites that may
be supported by sub-contractors to this award. The applicant will have
primary authority and responsibility to define objectives and approaches, to
plan, conduct, and analyze data, and to publish results, interpretations, and
conclusions of studies conducted under the terms and conditions of the
cooperative agreement award. In addition, the applicant is responsible for
coordination of the individual study with the CC. Recipient will:
a. identify and follow-up on occupational fatalities,
b. use mechanisms to ensure that data collection and management procedures
have necessary quality control and assure confidentiality of data,
c. serve as a permanent member of the CC,
d. submit semi-annual progress reports,
e. collaborate in the scientific reporting of findings,
f. provide program management oversight for the project, and
g. Coordinate human subject clearances through external IRBs.
2. NIOSH Responsibilities
NIOSH anticipates having substantial scientific programmatic involvement
during conduct of this activity, through technical assistance, advice, and
coordination. NIOSH will:
a. serve as a scientific liaison between the awardee and other program staff
at NIOSH with expertise in fatality assessment,
b. provide advice on formats for data reporting and coding, computer
software, and electronic storage of FACE surveillance and investigative data,
c. provide expert consultation in the area of occupational fatality
surveillance, epidemiology, on-site fatality investigation procedures, hazard
identification, prevention strategies, and dissemination methods, if
requested,
d. provide technical assistance in identifying sentinel events resulting
from industrial applications of new and emerging technologies, if requested,
e. facilitate collaborative efforts to compile and disseminate program
results through presentations and publications, and
f. assist in the development of human subjects protocols for the CDC
Institutional Review Board (if required) and in the preparation of OMB (and
other) clearances that may be required during the conduct of the study.
3. Collaborative Responsibilities
The CC will serve as the main governing board for the cooperative agreements
making up the FACE Consortium. The principal investigator at the recipient
organizations will have membership on the CC. NIOSH will have non-voting
representation on the CC.
Critical roles of the CC include ensuring that the study designs and data
collection protocols are uniform and compatible across the FACE Consortium
and developing broad-based measures and products to prevent fatal work
injury.
The CC may, when it deems necessary, invite additional, non-voting scientific
advisors to the meetings at which research priorities and opportunities are
discussed. A critical role of the CC will be the identification of sentinel
events that should be investigated.
It is anticipated that there will be two CC meetings during the first year
and two in each subsequent year, but the actual number and locations of the
meetings will be determined by the CC itself. The initial planning meeting
will be organized by NIOSH and held in Morgantown, WV soon after the award,
but subsequent meetings will be organized by the CC. The committee chair
will schedule the meetings and will be responsible for developing the meeting
agenda, chairing the meetings, and producing CC reports.
At the Planning Meeting, the CC may:
o discuss approaches for identifying fatal work injuries in a timely manner,
o discuss and set initial targeted events to be investigated by the FACE
Consortium,
o identify potential end-users of investigation data and identify future
products to be developed, and
o establish data sharing mechanisms.
At the second and subsequent meetings, the CC may: (1) make recommendations
on the study protocols and data collection approaches, (2) discuss the
targeted events that have been or will be investigated, (3) identify and
recommend solutions to unexpected study problems and (4) discuss ways to
efficiently coordinate and combine investigation data.
HUMAN SUBJECTS REQUIREMENTS
If a project involves research on human subjects, assurance (in accordance
with Department of Health and Human Services Regulations, 45 CFR Part 46) of
the protection of human subjects is required. In addition to other
applicable committees, Indian Health Service (IHS) institutional review
committees also must review the project if any component of IHS will be
involved with or will support the research. If any American Indian community
is involved, its tribal government must also approve that portion of the
project applicable to it. Unless the grantee holds a Multiple Project
Assurance, a Single Project Assurance is required, as well as an assurance
for each subcontractor or cooperating institution that has immediate
responsibility for human subjects. The Office of Human Research Protections
(OHRP) negotiates assurances for all activities involving human subjects that
are supported by the Department of Health and Human Services (Additional
information is available at http://www.hhs.gov/ohrp/).
INCLUSION OF WOMEN AND MINORITIES IN RESEARCH INVOLVING HUMAN SUBJECTS
It is the policy of the CDC to ensure that individuals of both sexes and the
various racial and ethnic groups will be included in CDC-supported research
projects involving human subjects, whenever feasible and appropriate. Racial
and ethnic groups are those defined in OMB Directive No. 15 and include
American Indian or Alaska Native, Asian, Black or African American, Hispanic
or Latino, Native Hawaiian or other Pacific Islander. Applicants shall
ensure that women, racial and ethnic minority populations are appropriately
represented in applications for research involving human subjects. Where
clear and compelling rationale exist that inclusion is inappropriate or not
feasible, this situation must be explained as part of the application. This
policy does not apply to research studies when the investigator cannot
control the race, ethnicity, and/or sex of subjects. Further guidance to
this policy is contained in the Federal Register, Vol. 60, No. 179, pages
47947-47951, and dated Friday, September 15, 1995.
All investigators proposing research involving human subjects should read the
UPDATED "NIH Guidelines for Inclusion of Women and Minorities as Subjects in
Clinical Research," published in the NIH Guide for Grants and Contracts on
August 2, 2000
(http://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-048.html),
a complete copy of the updated Guidelines are available at
http://grants.nih.gov/grants/funding/women_min/guidelines_update.htm: The
revisions relate to NIH defined Phase III clinical trials and require: a) all
applications or proposals and/or protocols to provide a description of plans
to conduct analyses, as appropriate, to address differences by sex/gender
and/or racial/ethnic groups, including subgroups if applicable, and b) all
investigators to report accrual, and to conduct and report analyses, as
appropriate, by sex/gender and/or racial/ethnic group differences.
URLS IN NIOSH GRANT APPLICATIONS OR APPENDICES
All applications must be self-contained within specified page limitations.
Unless otherwise specified, internet addresses (URLs) should not be used to
provide information necessary to the review because reviewers are under no
obligation to view the Internet sites. Reviewers are cautioned that their
anonymity may be comprised when they directly access an Internet site.
LETTER OF INTENT
Prospective applicants are asked to submit by January 12, 2001, a letter of
intent that includes a descriptive title of the proposed research, name,
address, and telephone number of the Principal Investigator, identities of
other key personnel and participating institutions, and number and title of
the RFA in response to which the application may be submitted.
Although a letter of intent is not required, is not binding, and does not
enter into the review of subsequent applications, the information allows
NIOSH staff to estimate the potential review workload and to avoid conflict
of interest in the review.
The letter of intent is to be sent to:
Gwendolyn Cattledge, Ph.D., M.S.E.H.
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention (CDC)
1600 Clifton Road, N.E.
Building 1, Room 3056, MS D-28
Atlanta, GA 30333
Telephone 404-639-2378
Fax 404-639-4175
Email: gcattledge@cdc.gov
APPLICATION PROCEDURES
Applicants must use Form PHS 398 (rev. 4/98). Application kits are available
at most institutional offices of sponsored research and may be obtained from
the Division of Extramural Outreach and Information Resources, National
Institutes of Health, 6701 Rockledge Drive, MSC 7910, Bethesda, MD 20892-
7910, telephone 301/710-0267, Email: grantsinfo@nih.gov. Application kits
are also available at: http://grants.nih.gov/grants/forms.htm.
The RFA label available in the PHS 398 (rev. 4/98) application form must be
affixed to the bottom of the face page of the application. Failure to use
this label could result in delayed processing of the application such that it
may not reach the review committee in time for review. In addition, the RFA
title and number must be typed on line 2 of the face page of the application
form and the YES box must be marked.
Submit a signed original of the application, including the Checklist, and
three signed photocopies, in one package to:
Center for Scientific Review (CSR)
National Institutes of Health
6701 Rockledge Drive, Room 1040 - MSC 7710
Bethesda, MD 20892-7710
Bethesda, MD 20817 (for express/courier service)
At the time of submission, two additional copies of the application must also
be sent to:
Gwendolyn Cattledge, Ph.D., M.S.E.H.
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention (CDC)
1600 Clifton Road, N.E.
Building 1, Room 3056, MS D-28
Atlanta, GA 30333
Telephone 404-639-2378
Fax 404-639-4175
Email: gcattledge@cdc.gov
Applications must be received by February 22, 2001. If an application is
received after that date, it will be returned to the applicant without
review. CSR and NIOSH will not accept any application in response to this
RFA that is essentially the same as one currently pending initial review,
unless the applicant withdraws the pending application. CSR and NIOSH will
not accept any application that is essentially the same as one already
reviewed. This does not preclude the submission of a substantial revision of
an application already reviewed, but such an application must follow the
guidance in the PHS Form 398 application instructions for the preparation of
revised applications, including an introduction addressing the previous
critique.
REVIEW CONSIDERATIONS
Upon receipt, applications will be reviewed for completeness by CSR and
responsiveness by NIOSH. Applications determined to be incomplete or
unresponsive to this RFA will be returned to the applicant without further
consideration. Those applications that are complete and responsive, will
undergo further scientific merit review in accordance with the criteria
stated below for scientific/technical merit by an appropriate peer review
group convened by NIOSH.
All applications will be judged on the basis of the scientific merit of the
proposed project and the documented ability of the investigators to meet the
RESEARCH OBJECTIVES of the RFA.
Following the scientific review, competitive applications will be reviewed
for programmatic importance by a NIOSH Secondary Review Committee.
Scientific Review Criteria
The review group will assess the scientific merit of the protocols and
related factors as follows:
Significance: Is the application relevant to the objectives outlined in the
RFA? Has the applicant described the scope and nature of occupational
fatalities in the applicant’s State?
Innovation: Does the project employ novel concepts, approaches or methods?
Are the aims original and innovative? Does the project challenge existing
paradigms or develop new methodologies or technologies?
Approach: Does the application provide a plan and a proposed schedule for
accomplishing each of the activities to be carried out in this project
including the implementation of surveillance, on-site field investigations,
dissemination and prevention components and a method for evaluating the
accomplishments? Does the plan include a description of the methods the
State will use to gain access to work sites for onsite investigations and
secure or review pertinent information, as well as methods to facilitate
collaboration with other State agencies involved in the investigation? Is
there a plan for internal review of investigative reports and any other
documents produced as a result of the program? Is there a plan to produce
and disseminate fatality narrative reports, data, and other information that
promotes the goals of increasing prevention activities? Is there an
evaluation plan to assess the impact of the project on reducing targeted
types of fatalities? Are the proposed schedule and personnel adequate for
accomplishing the proposed activities? Does the applicant acknowledge
potential problem areas and consider alternative approaches? Is the time
line proposed for the project suitable?
Investigators: Is the principal investigator and her/his collaborators
appropriately trained and well suited to carry out this work? Do they have
adequate experience and competence in surveillance activities? Do they have
experience in conducting occupational traumatic injury investigations?
Environment: Are the applicant’s facilities, equipment, and other resources
adequate for the performance of this project? Is there evidence of
institutional support generally, or specific agency commitment to development
of occupational fatality surveillance, investigation, and dissemination
activities? Are there letters of support or other documentation that
demonstrates the applicant’s ability to work with diverse groups, establish
linkages, and facilitate worker safety awareness information? Is there a
commitment to share surveillance data with other States in the program so as
to contribute to the goal of reducing fatalities across the nation?
In addition to the above criteria, all applications will also be reviewed
with respect to the following:
o The reasonableness of the proposed budget and duration in relation to the
proposed research.
o The adequacy of plans to include both genders, minorities and their
subgroups, for the scientific goals of the research.
o The adequacy of the proposed protection for humans, animals or the
environment, to the extent they may be adversely affected by the project
proposed in the application.
Programmatic Review Criteria:
o Magnitude of the problem in terms of numbers of workers affected.
o Likelihood of developing technical knowledge for the prevention of
occupational safety hazards on a national, regional, or State basis.
AWARD CONSIDERATIONS
Applications will be considered for award based upon (a) scientific merit,
(b) program importance, (c) program balance, and (d) availability of funds.
SCHEDULE
Letter of Intent Receipt Date: January 12, 2001
Application Receipt Date: February 22, 2001
Anticipated Award Date: September 1, 2001
INQUIRIES
Inquiries concerning this RFA are encouraged. The opportunity to clarify any
issues or questions from potential applicants is welcome. This RFA and other
CDC Announcements can be found on the CDC HomePage (http://www.cdc.gov) under
the Funding section (see Grants and Cooperative Agreements scroll down to
Occupational Safety and Health). This RFA can also be found on the NIOSH
HomePage (http://www.cdc.gov/niosh) under Extramural Programs, Current Funding
Opportunities.
Direct inquiries regarding programmatic issues to:
Roy M. Fleming, Ph.D.
Research Grants Program
National Institute for Occupational Safety and Health
Centers for Disease Control and Prevention
1600 Clifton Road, N.E.
Building 1, Room 3053, MS D-30
Atlanta, GA 30333
Telephone: 404/639-3343
FAX: 404/639-4616
Email: rfleming@cdc.gov
Direct inquiries regarding grants management to:
Sheryl L. Heard, Grants Management Specialist
Grants Management Branch, Procurement and Grants Office
Centers for Disease Control and Prevention (CDC)
2920 Brandywine Road, Room 3000
Atlanta, Georgia 30341
Telephone: (770) 488-2723
Email address: slh3@cdc.gov
PAPERWORK REDUCTION ACT
Projects that involve the collection of information from 10 or more
individuals and funded by cooperative agreement will be subject to review by
the Office of Management and Budget (OMB) under the Paperwork Reduction Act.
AUTHORITY AND REGULATIONS
The Catalog of Federal Domestic Assistance number is: 93.262 for the National
Institute for Occupational Safety and Health (NIOSH). This program is
authorized under the Public Health Service Act, as amended, Section 301(a)
[42 U.S.C. 241(a)], and the Occupational Safety and Health Act of 1970,
Section 20(a) [29 U.S.C. 669(a)]. The applicable program regulation is 42
CFR Part 52. This program is subject to the intergovernmental review
requirements of Executive Order 12372.
LOBBYING RESTRICTIONS
Applicants should be aware of restrictions on the use of HHS funds for
lobbying of Federal or State legislative bodies. Under the provisions of 31
U.S.C. Section 1352, recipients (and their sub-tier contractors) are
prohibited from using appropriated Federal funds (other than profits from a
Federal contract) for lobbying congress or any Federal agency in connection
with the award of a particular contract, grant, cooperative agreement, or
loan. This includes grants/cooperative agreements that, in whole or in part,
involve conferences for which Federal funds cannot be used directly or
indirectly to encourage participants to lobby or to instruct participants on
how to lobby.
In addition, no part of CDC appropriated funds, shall be used, other than for
normal and recognized executive-legislative relationships, for publicity or
propaganda purposes, for the preparation, distribution, or use of any kit,
pamphlet, booklet, publication, radio, television, or video presentation
designed to support or defeat legislation pending before the Congress or any
State or local legislature, except in presentation to the Congress or any
State or local legislature itself. No part of the appropriated funds shall be
used to pay the salary or expenses of any grant or contract recipient, or
agent acting for such recipient, related to any activity designed to
influence legislation or appropriations pending before the Congress or any
State or local legislature.
SMOKE-FREE WORKPLACE
The CDC strongly encourages all grant and contract recipients to provide a
smoke-free workplace and promote the non-use of all tobacco products. In
addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking
in certain facilities (or in some cases, any portion of a facility) in which
regular or routine education, library, day care, health care, or early
childhood development services are provided to children. This is consistent
with the PHS mission to protect and advance the physical and mental health of
the American people.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
|
|
|
Department of Health and Human Services (HHS)
|
|
|
|
NIH... Turning Discovery Into Health®
|